Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has provided an update.
Jiangsu Recbio Technology Co., Ltd. has announced its participation in the H Share Full Circulation Plan, aiming to convert 141,953,490 unlisted shares into H shares. This strategic move is expected to significantly increase the company’s H share count to 94.85% of its total share capital, enhancing liquidity and potentially strengthening its market position on the Hong Kong Stock Exchange.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biotechnology sector. The company is focused on developing and commercializing innovative vaccines and related technologies, with a market focus on expanding its share circulation and enhancing its presence on the Hong Kong Stock Exchange.
Average Trading Volume: 106,826
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.4B
For an in-depth examination of 2179 stock, go to TipRanks’ Stock Analysis page.